Identifying risk factors for infections in children with drug-resistant bacteria

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on children hospitalized in the pediatric intensive care unit (PICU) at Children's Hospital of Fudan University from January 2018 to December 2019. The aim is to identify risk factors associated with colonization or infection by carbapenem-resistant Enterobacteriaceae (CRE) and to analyze the microbiological characteristics of the CRE isolates. By reviewing clinical and demographic data from electronic health records, the study will categorize patients based on their culture results into non-CRE, CRE colonization, and CRE infection groups. This research addresses a critical gap in understanding the epidemiology of CRE in pediatric patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All children hospitalized in PICU of Children's Hospital of Fudan University from January 2018 to December 2019.

Exclusion Criteria:

* discharge within 48 hours
* patients had a positive culture for CRE before admission
* incomplete clinical and demographic data

Where it's running

• Children's Hospital of Fudan University
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Principal investigator: Gangfeng Yan — Children's Hospital of Fundan University
• Study coordinator: Gangfeng Yan
• Email: jinyi036@126.com
• Phone: +8615900603082

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Aztreonam-Avibactam in Immunocompromised Patients with Multidrug-Resistant Infections

  This study tests how well and how safely aztreonam-avibactam works in adults with weakened immune systems who have highly resistant Enterobacterales infections.

  Recruiting Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno · Buenos Aires, City of Buenos Aires · NCT07890480

• Jet versus vibrating mesh inhalation of polymyxin B for ventilated patients with carbapenem‑resistant Gram‑negative pneumonia

  This trial tests whether jet nebulizers or vibrating mesh nebulizers deliver inhaled polymyxin B more effectively for mechanically ventilated patients with carbapenem‑resistant Gram‑negative pneumonia.

  Recruiting Fujian Medical University Union Hospital · Fuzhou, Fujian · NCT07086391

• Using Colistimethate Sodium to Treat Infections from Carbapenem-Resistant Bacteria

  This study is testing if colistimethate sodium can help hospitalized patients with infections from tough-to-treat bacteria feel better compared to standard treatments.

  Recruiting at 15 sites Southeast University, China · Hefei, Anhui and 14 other locations · NCT06051513

• Early treatment with targeted antibiotics for severe infections using rapid diagnostics

  This study is testing if giving targeted antibiotics right away, based on quick test results, can help hospitalized patients with severe infections caused by tough-to-treat bacteria feel better faster than standard care.

  Recruiting at 21 sites Phase 4 National University of Singapore · Vellore and 20 other locations · NCT05979545

• Reducing the spread of antibiotic-resistant infections from hospitals to communities

  This study is testing a set of strategies to see if they can help stop the spread of antibiotic-resistant infections from hospitals to families and communities.

  Recruiting Hanoi University of Public Health · Thái Bình, Thai Binh · NCT05871476

• Using fecal microbiota transplantation to treat gut disorders

  This study is testing whether a treatment that involves using healthy stool to help restore gut bacteria can improve symptoms for people with gut disorders like Crohn's disease and irritable bowel syndrome.

  Recruiting Chinese University of Hong Kong · Hong Kong, Shatin · NCT04014413

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.